The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.s

Vasculitis, pulmonary (w/wo AH), extrapulmonary, systemic: ANCA-positive

Publications

Konishi M, Koarada S, Yamaguchi K, Tashiro S, Soejima S, Suematsu R, Inoue H, Tada Y, Ohta A, Nagasawa K

[Case of microscopic polyangiitis and giant cell arteritis after influenza vaccination].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology. 2011;34(3):154-61

Birck R, Kaelsch I, Schnuelle P, Flores-Suárez LF, Nowack R

ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2009;15(6):289-91

Uji M, Matsushita H, Iwata S

Microscopic polyangiitis after influenza vaccination.

Internal medicine (Tokyo, Japan). 2005;44(8):892-6